位置:成果数据库 > 期刊 > 期刊详情页
慢性心力衰竭本虚标实证分类方案在病证结合模式中的优势
  • ISSN号:1003-7705
  • 期刊名称:《湖南中医杂志》
  • 时间:0
  • 分类:R259.416.1[医药卫生—中西医结合;医药卫生—中医内科学;医药卫生—中医学]
  • 作者机构:[1]天津中医药大学,天津300193, [2]天津中医药大学第二附属医院,天津300150
  • 相关基金:国家自然科学基金资助项目(编号:81173159);国家自然科学基金青年基金项目(编号:81101512); 天津市卫生局课题(编号:2015123); 天津市中医药管理局中医、中西医结合科研课题(编号:11053); 天津市中医药管理局、国家中医药管理局重点专科建设项目; 高等学校博士学科点专项科研基金项目(编号:20121210110009)
中文摘要:

由于慢性心力衰竭(Chronic heart failure,CHF)具有迁延难愈、证候复杂多变的特点,决定了中药及其复方对CHF治疗应该分阶段、分层次进行,才能体现其多途径、多靶点的综合优势。但目前对慢性心力衰竭的中医证候要素、证候类型及其演变规律尚缺乏统一的认识,疗效无法得到认可,优势无法得以体现,严重制约了中医药在临床中的推广和对本病防治的公信力。基于以上认识,将慢性心力衰竭分为加重期和缓解期两期,加重期以标实证分类,寒热分治;缓解期以本虚证分类,在阴阳、气血辨证的基础上,依脏腑(三焦辨证)进行系统论治。

英文摘要:

Chronic heart failure( CHF) is difficult to cure due to its long course and complex and changeable syndromes. Therefore,the traditional Chinese medicine( TCM) therapy for CHF should be developed based on the different stages and classifications of CHF,which can reflect its comprehensive advantages of multiple ways and targets. However,there is no consensus about TCM syndrome factors,syndrome types,and syndrome patterns of CHF,so the therapeutic efficacy of TCM is not accepted and its advantages cannot be shown,which significantly restricts its clinical application and its credibility in the prevention and treatment of CHF. Based on the above knowledge,CHF is staged as exacerbation and remission; for CHF in the exacerbation stage,the therapy should be classified according to excess in superficiality and differentiated for cold or heat; for CHF in the remission stage,the therapy should be classified according to deficiency in origin and performed based on syndrome differentiation of viscera and bowels( Triple Energizer) in addition to syndrome differentiation of yin- yang and qi- blood.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《湖南中医杂志》
  • 主管单位:湖南省卫生和计划生育委员会
  • 主办单位:湖南省中医药研究院
  • 主编:黄惠忠
  • 地址:长沙市麓山路58号
  • 邮编:410006
  • 邮箱:hnzy188@sohu.com
  • 电话:0731-8888572
  • 国际标准刊号:ISSN:1003-7705
  • 国内统一刊号:ISSN:43-1105/R
  • 邮发代号:42-71
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:17257